Items where Author is "Nivathra, V"

Article

Nivathra, V and SUDHARSHAN, K and sreenath, v and Padhma Shri, babu and UNSPECIFIED1 and UNSPECIFIED1 (2026) Quantum Dot - Based Spectroscopy for Vonoprazan in Nanomedicine Applications. Quantum Dot - Based Spectroscopy for Vonoprazan in Nanomedicine Applications, 14 (4). pp. 295-313. ISSN 2320-2882

Nivathra, V and Namrata singh, N and Afsha khan, A and Pooja jha, P and Bimal debbarma, B and Prashant upadhyay, P and santhoshkumar, S P and Boi bsantakumar reddy, B (2026) Formulation And In Vitro And In Vivo Evaluation Of Ligand Functionalized Liposomes For Targeted Cancer Therapy. Formulation And In Vitro And In Vivo Evaluation Of Ligand Functionalized Liposomes For Targeted Cancer Therapy, 16 (11). pp. 367-378.

Conference or Workshop Item

Nivathra, V (2026) GREEN SYNTHESIS OF NANO PARTICLES FOCUSING ON THERAPEUTIC POTENTIAL AND BIOCOMPATABILITY. In: INNOVATIONS & START UP OPPORTUNITIES IN PHARMACEUTICAL RESEARCH, 31.01.2026, SANGAREDDY.

Muthukumaran, S and Nivathra, V and Arivazhagan, P (2025) An Integrated Multi-Clustering Approach for Patient Stratification and Disease Prediction Using Electronic Medical Records in Vector-Borne Diseases. In: National Conference on NextGen Computing and Future Technologies, 10.10.2025, VISTAS.

Sudharsan, K and Nivathra, V (2025) ADVANCED METABOLITE IDENTIFICATION IN PRECLINICAL DRUG RESEARCH USING HIGH.RESOLUTION MASS SPECTROMETRY. In: 2ND ICCPPR, 25.09.2025 & 26.09.2025, VISTAS.

Thagasin, S and Nivathra, V (2025) Integrative Analysis Of Tumor Genomics and Host Pharmacogenomics to Improve Therapeutic Outcomes in Colorectal Cancer. In: 2ND ICCPPR.

Poonguzhali, T and Nivathra, V (2025) NEXT GEN ADVANCEMENT IN GREEN CHEMISTRY RELATED TO PHARMACEUTICAL ANALYSIS. In: 2ND ICCPPR.

Padhma shri babu, B and Nivathra, V (2025) TARGETED NANOFORMULATIONS OF PHYTOCHEMICALS IN IBD MANAGEMENT. In: 2ND ICCPPR.

Theyshnee, S and Nivathra, V (2025) Therapeutic Conyergence: AI, CRISPR, and Pharmacogenomics for Mutation-Centric Medicine. In: 2ND ICCPPR.